Patents targeting cannabinoid receptor type 2 ligands: an interview with Uwe Grether.

作者信息

Grether Uwe

机构信息

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.

出版信息

Pharm Pat Anal. 2021 Jul;10(4):175-177. doi: 10.4155/ppa-2021-0013. Epub 2021 Aug 9.

DOI:10.4155/ppa-2021-0013

PMID:34365800

Abstract

摘要

相似文献

Patents targeting cannabinoid receptor type 2 ligands: an interview with Uwe Grether.

Pharm Pat Anal. 2021 Jul;10(4):175-177. doi: 10.4155/ppa-2021-0013. Epub 2021 Aug 9.

Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010.

Pharm Pat Anal. 2021 May;10(3):111-163. doi: 10.4155/ppa-2021-0002. Epub 2021 Jun 11.

Structural and Functional Insights into Cannabinoid Receptors.

Trends Pharmacol Sci. 2020 Sep;41(9):665-677. doi: 10.1016/j.tips.2020.06.010. Epub 2020 Jul 29.

The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.

Eur J Neurosci. 2022 Feb;55(4):909-921. doi: 10.1111/ejn.14982. Epub 2020 Dec 5.

Cannabinoid receptors and their ligands.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):101-21. doi: 10.1054/plef.2001.0341.

Is GPR55 an anandamide receptor?

Vitam Horm. 2009;81:111-37. doi: 10.1016/S0083-6729(09)81005-4.

Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.

Curr Med Chem. 2010;17(14):1468-86. doi: 10.2174/092986710790980005.

Endocannabinoid receptor pharmacology.

Curr Top Behav Neurosci. 2009;1:37-63. doi: 10.1007/978-3-540-88955-7_2.

Endocannabinoids and Their Pharmacological Actions.

Handb Exp Pharmacol. 2015;231:1-37. doi: 10.1007/978-3-319-20825-1_1.

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

Br J Pharmacol. 2011 Aug;163(7):1329-43. doi: 10.1111/j.1476-5381.2011.01364.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Patents targeting cannabinoid receptor type 2 ligands: an interview with Uwe Grether.

Pharm Pat Anal. 2021 Jul;10(4):175-177. doi: 10.4155/ppa-2021-0013. Epub 2021 Aug 9.

Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010.

Pharm Pat Anal. 2021 May;10(3):111-163. doi: 10.4155/ppa-2021-0002. Epub 2021 Jun 11.

Structural and Functional Insights into Cannabinoid Receptors.

Trends Pharmacol Sci. 2020 Sep;41(9):665-677. doi: 10.1016/j.tips.2020.06.010. Epub 2020 Jul 29.

The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.

Eur J Neurosci. 2022 Feb;55(4):909-921. doi: 10.1111/ejn.14982. Epub 2020 Dec 5.

Cannabinoid receptors and their ligands.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):101-21. doi: 10.1054/plef.2001.0341.

Is GPR55 an anandamide receptor?

Vitam Horm. 2009;81:111-37. doi: 10.1016/S0083-6729(09)81005-4.

Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.

Curr Med Chem. 2010;17(14):1468-86. doi: 10.2174/092986710790980005.

Endocannabinoid receptor pharmacology.

Curr Top Behav Neurosci. 2009;1:37-63. doi: 10.1007/978-3-540-88955-7_2.

Endocannabinoids and Their Pharmacological Actions.

Handb Exp Pharmacol. 2015;231:1-37. doi: 10.1007/978-3-319-20825-1_1.

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

Br J Pharmacol. 2011 Aug;163(7):1329-43. doi: 10.1111/j.1476-5381.2011.01364.x.